Acne Reparatif

Description

No relevant information is available for SPL code 34089-3.

Uses and Indications

This drug is indicated for the treatment of acne. It is intended for use in patients diagnosed with acne vulgaris, providing therapeutic benefits to manage and reduce the severity of this condition.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of the medication. The affected area should be covered with a thin layer of the product, applied 1 to 3 times daily, while avoiding the eye area.

To minimize the risk of excessive skin drying, it is recommended to initiate treatment with a single application per day. Depending on the patient's response and as directed by a physician, the frequency may be increased to 2 or 3 times daily. In cases where bothersome dryness or peeling occurs, the application frequency should be reduced to once daily or every other day.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

For external use only. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

When utilizing this product, it is imperative to apply it solely to the affected areas. Concurrent use of other topical acne medications may exacerbate skin dryness or irritation. Should any irritation arise, it is recommended to limit the use to one medication at a time to mitigate adverse effects.

Side Effects

Patients should be aware that this product is for external use only. The use of this medication in conjunction with other topical acne treatments may lead to increased dryness or irritation of the skin. In the event that irritation occurs, it is advised to use only one medication at a time to mitigate these effects.

Additionally, it is crucial to keep this product out of reach of children. If the product is swallowed, patients should seek medical assistance or contact a Poison Control Center immediately.

Drug Interactions

Concurrent use of other topical acne medications may lead to increased dryness or irritation of the skin. In cases where irritation is observed, it is advisable to limit the use to one topical acne medication at a time to mitigate these effects. Monitoring for signs of skin irritation is recommended to ensure patient comfort and treatment efficacy.

Packaging & NDC

Below are the non-prescription pack sizes of Acne Reparatif (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely when using this medication. It is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

For topical application, it is recommended to start with one application daily to minimize the risk of excess drying of the skin. Depending on the patient's response, the frequency may be increased to two or three times daily, or as directed by a physician. Should bothersome dryness or peeling occur, the application frequency should be reduced to once a day or every other day.

Geriatric Use

There is no specific information regarding the use of Acne Reparatif (salicylic acid gel) in geriatric patients. The prescribing information does not provide details on dosage adjustments, safety concerns, or special precautions that may be necessary for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when prescribing this medication to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of treatment efficacy and safety in this population.

Pregnancy

The product has not been specifically studied in pregnant patients, and there are no documented safety concerns related to its use during pregnancy. Additionally, there are no dosage modifications recommended for pregnant individuals. As such, healthcare professionals should consider the absence of specific data when prescribing this product to women of childbearing potential. It is advisable to weigh the potential benefits against any unknown risks when making treatment decisions for pregnant patients.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific concerns have been identified in the available information.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the medication is swallowed.

Patients should be instructed to apply the medication only to the affected areas to ensure proper use and minimize potential side effects.

It is important for healthcare providers to inform patients that using this medication in conjunction with other topical acne treatments may lead to increased dryness or irritation of the skin. If patients experience irritation, they should be counseled to use only one medication at a time to avoid exacerbating the condition.

Storage and Handling

The product is supplied in a container that must be protected from heat and flame. It is essential to keep the container tightly closed to maintain the integrity of the product. Proper storage conditions are crucial to ensure the product's efficacy and safety.

Additional Clinical Information

The medication is administered topically, with a recommended application of a thin layer to the entire affected area 1 to 3 times daily. Clinicians should advise patients to avoid the eye area and to start with one application daily to minimize the risk of excess skin drying. If necessary, the frequency may be increased to two or three times daily, as directed by a physician. Should patients experience bothersome dryness or peeling, they are advised to reduce the application frequency to once a day or every other day.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Acne Reparatif, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)